Detalhe da pesquisa
1.
Metabolomics as a tool to predict the risk of decompensation or liver-related death in patients with compensated cirrhosis.
Hepatology
; 77(6): 2052-2062, 2023 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36811400
2.
Point-of-Care Noninvasive Prediction of Liver-Related Events in Patients With Nonalcoholic Fatty Liver Disease.
Clin Gastroenterol Hepatol
; 2023 Aug 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37573987
3.
An international survey on patterns of practice in NAFLD and expectations for therapies-The POP-NEXT project.
Hepatology
; 76(6): 1766-1777, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35363906
4.
Population screening for liver fibrosis: Toward early diagnosis and intervention for chronic liver diseases.
Hepatology
; 75(1): 219-228, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34537988
5.
Prediction of clinical events by liver stiffness and chronic kidney disease by NAFLD in patients with type-2 diabetes.
Gastroenterol Hepatol
; 46(9): 682-691, 2023 Nov.
Artigo
em Inglês, Espanhol
| MEDLINE | ID: mdl-36435379
6.
[Metabolic morbidity in the prison population of Catalonia, Spain]. / Morbilidad metabólica en la población penitenciaria de Cataluña.
Aten Primaria
; 55(6): 102620, 2023 06.
Artigo
em Espanhol
| MEDLINE | ID: mdl-37043974
7.
Decompensation in Advanced Nonalcoholic Fatty Liver Disease May Occur at Lower Hepatic Venous Pressure Gradient Levels Than in Patients With Viral Disease.
Clin Gastroenterol Hepatol
; 20(10): 2276-2286.e6, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34688952
8.
Prevalence estimation of significant fibrosis because of NASH in Spain combining transient elastography and histology.
Liver Int
; 42(8): 1783-1792, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35643936
9.
Bacterial infections adversely influence the risk of decompensation and survival in compensated cirrhosis.
J Hepatol
; 75(3): 589-599, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33905794
10.
Noninvasive Diagnosis of Portal Hypertension in Patients With Compensated Advanced Chronic Liver Disease.
Am J Gastroenterol
; 116(4): 723-732, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33982942
11.
Outcomes and potential surrogate markers for future clinical trials of non-alcoholic steatohepatitis cirrhosis.
Liver Int
; 41(9): 1999-2008, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34242466
12.
Disease burden and economic impact of diagnosed non-alcoholic steatohepatitis in five European countries in 2018: A cost-of-illness analysis.
Liver Int
; 41(6): 1227-1242, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33590598
13.
Definite and indeterminate nonalcoholic steatohepatitis share similar clinical features and prognosis: A longitudinal study of 1893 biopsy-proven nonalcoholic fatty liver disease subjects.
Liver Int
; 41(9): 2076-2086, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33896100
14.
Overall clinical and economic impact of non-alcoholic fatty liver disease.
Rev Esp Enferm Dig
; 113(6): 396-403, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-33222473
15.
Non-invasive prediction of liver-related events in patients with HCV-associated compensated advanced chronic liver disease after oral antivirals.
J Hepatol
; 72(3): 472-480, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31629779
16.
Significant fibrosis predicts new-onset diabetes mellitus and arterial hypertension in patients with NASH.
J Hepatol
; 73(1): 17-25, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32147361
17.
ß blockers to prevent decompensation of cirrhosis in patients with clinically significant portal hypertension (PREDESCI): a randomised, double-blind, placebo-controlled, multicentre trial.
Lancet
; 393(10181): 1597-1608, 2019 Apr 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-30910320
18.
Lowering Portal Pressure Improves Outcomes of Patients With Cirrhosis, With or Without Ascites: A Meta-Analysis.
Clin Gastroenterol Hepatol
; 18(2): 313-327.e6, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31176013
19.
Steatosis as main determinant of portal hypertension through a restriction of hepatic sinusoidal area in a dietary rat nash model.
Liver Int
; 40(11): 2732-2743, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32770818
20.
Simvastatin-loaded polymeric micelles are more effective and less toxic than conventional statins in a pre-clinical model of advanced chronic liver disease.
Nanomedicine
; 29: 102267, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32681987